Moleculin Biotech

$3.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-5.23%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MBRX and other stocks, options, and ETFs commission-free!

About MBRX

Moleculin Biotech, Inc. Common Stock, also called Moleculin Biotech, is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses.

CEO
Walter V. Klemp
Employees
15
Headquarters
Houston, Texas
Founded
2015
Market Cap
97.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.96M
High Today
$3.60
Low Today
$3.37
Open Price
$3.60
Volume
986.79K
52 Week High
$9.30
52 Week Low
$3.16

MBRX Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

CODI-B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure